The National Institutes of Health has halted research into the use of convalescent plasma (blood plasma from patients who have recovered from COVID-19 illness) to treat patients in the emergency department with mild to moderate COVID-19…

Johnson & Johnson’s (J&J) one-dose, easily stored COVID-19 vaccination recently received Emergency Use Authorization from the United States Food and Drug Administration, increasing the number of immunizations available to the…

With weeks of declining case numbers and increasing pandemic fatigue, many states are loosening COVID-19 restrictions, such as eliminating mask mandates and capacity restrictions. United States Centers for Disease Control and Prevention…

Good news regarding the global pandemic has abounded in recent weeks, and nowhere has that been more apparent than in nursing homes. Originally the hardest hit with more than 162,000 deaths attributed to COVID-19 illness since the start of…

According to a Time Magazine-Harris Poll taken between February 12 and 17, approximately 30% of Americans have postponed regular dental care due to fear of contracting COVID-19. The data also showed that 78% of Americans had put off at…

For those who have recovered from COVID-19, one dose of the Pfizer vaccine offers significant, long-lasting protection, according to two research studies recently published in The Lancet. It is thought that one dose of the Pfizer vaccine…

Adding to a continuing stream of good news surrounding the COVID-19 pandemic, research from the National Institutes of Health has found that individuals who have recovered from COVID-19 are unlikely to become reinfected with the novel…

The United States Food and Drug Administration (FDA) released its own analysis of Johnson & Johnson’s (J&J) one-shot, easily stored COVID-19 vaccine, finding that the immunization protects against severe COVID-19 illness and death,…

The global pandemic has severely impacted minority populations in the United States, and Hispanic populations have been among some of the hardest hit. COVID-19 illness has disproportionately impacted Hispanic people in addition to the…

Pfizer, maker of one of the two currently approved COVID-19 vaccinations, has asked the United States Food and Drug Administration (FDA) to adjust its vaccine’s required storage temperature from -112°F to -76°F to -13°F to -5°F. The new…